[Comparative molecular field analysis (CoMFA) of allylamine antimycotics]. 1997

H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
School of Pharmacy, Second Military Medical University, Shanghai 200433.

Active analog approach has been applied to determine the pharmacophoric conformations of the allylamine antimycotics. Comparative molecular field analysis (CoMFA) has been used to establish 3D-QSAR of 48 allylamine antimycotics against six common human pathogenic fungi. Two different alignment rules were compared in the meantime. Five new synthetic compounds have been successfully employed to examine the predictive abilities of the CoMFA models against Trichophyton mentagrophytes and Aspergillus fumigatus.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D000499 Allylamine Possesses an unusual and selective cytotoxicity for VASCULAR SMOOTH MUSCLE cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation. 3-Aminopropylene,3 Aminopropylene
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001232 Aspergillus fumigatus A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals. Aspergillus fumigates,Neosartorya fumigata,Sartorya fumigata
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014249 Trichophyton A mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair. Endodermophyton,Trychophyton,Endodermophytons,Trichophytons,Trychophytons
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
January 1989, Progress in clinical and biological research,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
June 1998, Archiv der Pharmazie,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
August 2003, Bioorganic & medicinal chemistry letters,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
December 1998, Bioorganic & medicinal chemistry,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
August 2011, European journal of medicinal chemistry,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
September 2000, Steroids,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
September 2003, Journal of medicinal chemistry,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
December 2006, Journal of medicinal chemistry,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
June 2017, Chemical biology & drug design,
H T Ji, and W N Zhang, and Y J Zhou, and J G Lu, and K Li, and J Zhu, and N Liu
September 2002, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!